Key terms
About BNTX
BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest BNTX news
Apr 17
6:20am ET
Analysts Are Bullish on These Healthcare Stocks: BioNTech SE (BNTX), Connect Biopharma Holdings (CNTB)
Apr 08
5:27pm ET
BioNTech SE Virtual AGM Scheduled for May 2024
Apr 08
7:57am ET
BioNTech Reports Promising Cancer Vaccine Data
Apr 07
4:40pm ET
BioNTech announces Phase 1 trial follow up data for mRNA-based iNeST candidate
Mar 27
7:03am ET
BioNTech price target lowered to $101 from $110 at UBS
Mar 24
9:26pm ET
Optimistic Outlook for BioNTech: A Buy Rating Amidst Vaccine Demand and Strong Oncology Pipeline
Mar 22
1:00pm ET
BioNTech price target lowered to $90 from $99 at JPMorgan
Mar 22
11:33am ET
Biotech Alert: Searches spiking for these stocks today
Mar 22
6:58am ET
BioNTech price target lowered to $90 from $115 at HSBC
Mar 22
6:21am ET
Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Intuitive Surgical (ISRG) and Bolt Biotherapeutics (BOLT)
Mar 21
2:12pm ET
BioNTech price target lowered to $146 from $159 at BofA
Mar 21
10:35am ET
Hold Rating for BioNTech: Navigating Vaccine Revenue Decline and Prospective Oncology Pipeline
Mar 21
8:01am ET
Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Edwards Lifesciences (EW) and Innovent Biologics (OtherIVBXF)
Mar 21
7:40am ET
Analysts Are Bullish on These Healthcare Stocks: Insulet (PODD), Annovis Bio (ANVS)
Mar 21
6:31am ET
Analysts Are Bullish on Top Healthcare Stocks: Femasys (FEMY), BioNTech SE (BNTX)
Mar 21
2:01am ET
Biontech’s Bold AI Leap: Navigating Risks and Competition in the Tech Integration Era
Mar 20
9:05pm ET
Maintaining Hold on BioNTech: A Balancing Act Between Near-Term Challenges and Long-Term Oncology Investment
Mar 20
5:55pm ET
Jefferies Keeps Their Hold Rating on BioNTech SE (BNTX)
Mar 20
10:05am ET
UBS Keeps Their Hold Rating on BioNTech SE (BNTX)
Mar 20
8:28am ET
BioNTech Expects Continued Growth into 2024
Mar 20
8:05am ET
Options Volatility and Implied Earnings Moves Today, March 20, 2024
Mar 20
7:57am ET
BioNTech Welcomes New Chief Commercial Officer
Mar 20
6:18am ET
BioNTech sees FY24 CapEx EUR 400M-EUR 500M
Mar 20
6:17am ET
BioNTech sees FY24 revenue EUR 2.5B-EUR 3.1B
Mar 20
6:16am ET
BioNTech reports Q4 EPS EUR 1.90 vs. EUR 9.26 last year
Mar 20
6:02am ET
BioNTech names Annemarie Hanekamp as Chief Commercial Officer
Mar 19
12:19am ET
Novavax (NASDAQ:NVAX): A Highly Speculative Value Trade in the Post-Pandemic Era
Mar 18
9:22am ET
Autolus Therapeutics price target raised to $10 from $9 at Truist
Mar 18
8:00am ET
Options Volatility and Implied Earnings Moves This Week, March 18 – March 21, 2024
Mar 11
7:55am ET
BioNTech to present clinical data updates for oncology candidates
Mar 07
6:50am ET
BioNTech Chief Business and Commercial Officer, Sean Marett, to retire
BNTX Financials
Key terms
Ad Feedback
BNTX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
BNTX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
